Kadimastem Ltd (TLV:KDST)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2,565.00
-27.00 (-1.04%)
Aug 5, 2025, 4:43 PM IDT

Kadimastem Company Description

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases.

Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes.

The company was incorporated in 2008 and is based in Ness Ziona, Israel.

Kadimastem Ltd
Kadimastem logo
CountryIsrael
Founded2008
IndustryBiotechnology
SectorHealthcare
Employees11
CEORonen Twito

Contact Details

Address:
Pinchas Sapir 7
Ness Ziona, 74140
Israel
Phone972 73 797 1600
Websitekadimastem.com

Stock Details

Ticker SymbolKDST
ExchangeTel Aviv Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyILS
ISIN NumberIL0011284614
SIC Code2836

Key Executives

NamePosition
Ronen Twito CPAChief Executive Officer and Executive Chairman
Prof. Michel Revel M.D., Ph.D.Co-Founder, Chief Scientist, Head of the Scientific Advisory Board and Director
Yossi Ben-YossefHonorary President and Strategic Consultant
Uri Ben-OrChief Financial Officer
Olivier SamuelVice President of Research and Development and Director